Table 29.
Country | N | GEN | CHL | AMP | CTX | CAZ | MEM | TGC |
---|---|---|---|---|---|---|---|---|
Austriaa | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Croatia | 25 | 0 | 0 | 4 | 0 | 0 | 0 | 0 |
Cyprusa | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Germanya | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hungary | 50 | 6 | 2 | 22 | 0 | 0 | 0 | 8 |
Polanda | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Spaina | 2 | 0 | 50 | 0 | 0 | 0 | 0 | 0 |
Total (7 MSs) | 83 | 3.6 | 2.4 | 14.5 | 0 | 0 | 0 | 4.8 |
Country | N | NAL | CIP | AZM | COL | SMX | TMP | TET |
---|---|---|---|---|---|---|---|---|
Austriaa | 3 | 66.7 | 66.7 | 0 | 0 | 66.7 | 0 | 66.7 |
Croatia | 25 | 92 | 92 | 0 | 0 | 4 | 0 | 8 |
Cyprusa | 1 | 100 | 100 | 0 | 0 | 100 | 100 | 100 |
Germanya | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hungary | 50 | 96 | 98 | 0 | 0 | 96 | 4 | 98 |
Polanda | 1 | 100 | 100 | 0 | 0 | 100 | 0 | 100 |
Spaina | 2 | 0 | 0 | 0 | 0 | 50 | 50 | 50 |
Total (7 MSs) | 83 | 90.4 | 91.6 | 0 | 0 | 65.1 | 4.8 | 67.5 |
ECOFFs: epidemiological cut‐off values; EUCAST: European Committee on Antimicrobial Susceptibility Testing; N: number of isolates tested; MSs: Member States; GEN: gentamicin; CHL: chloramphenicol; AMP: ampicillin; CTX: cefotaxime; CAZ: Ceftazidime; MEM: meropenem; TGC: tigecycline; NAL: nalidixic acid; CIP: ciprofloxacin; AZM: azithromycin; COL: colistin; SMX: sulfamethoxazole; TMP: trimethoprim; TET: tetracycline.
The occurrence of resistance is assessed on less than 10 isolates and should only be considered as part of the total from all MSs data.